Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale. Image Credit: Univercells The move builds on lessons the … Read more

City Schools holds vaccine clinics at district office

City Schools holds vaccine clinics at district office

Baltimore City Public Schools holds vaccine clinics at district office District intends to help families get kids vaccinated Updated: 4:44 PM EDT Sep 22, 2023 Baltimore City Public Schools leaders remain on a mission to vaccinate thousands of students.This is the first year that administrators opened district headquarters to offer shots. Some might say the … Read more

Study finds risk factors linked to lower flu vaccine uptake in people with kidney disease

Study finds risk factors linked to lower flu vaccine uptake in people with kidney disease

Among adults with chronic kidney disease (CKD) enrolled in the Chronic Renal Insufficiency Cohort (CRIC), young age, Black race, and low levels of education and income were associated with lower likelihood of getting an annual flu shot. Identifying risk factors for not receiving a flu vaccine (“non-vaccination”) in people living with kidney disease, who are … Read more

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Recently published research from the University of Minnesota Medical School suggests individuals with hepatitis C should consider revaccination for hepatitis B. The study was published in the Journal of Infectious Diseases. Previous research has shown individuals with hepatitis C infection have a lower response to the hepatitis B virus (HBV) vaccine. This study has broad … Read more

Vaccine: US FDA approves Pfizer’s maternal RSV vaccine to protect infants

Vaccine: US FDA approves Pfizer’s maternal RSV vaccine to protect infants

The US Food and Drug Administration on Monday approved Pfizer‘s respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies. The approval allows the vaccine to be given to women 32 to 36 weeks into a pregnancy to prevent lower respiratory tract infection … Read more